Metropolitan Life Insurance Company (MetLife)’s TransDigm Group TDG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,243
| Closed | -$2.76M | – | 1894 |
|
|
2024
Q1 | $2.76M | Sell |
2,243
-10
| -0.4% | -$11.3K | 0.12% | 151 |
|
|
2023
Q4 | $2.28M | Sell |
2,253
-31
| -1% | -$28.6K | 0.11% | 166 |
|
|
2023
Q3 | $1.93M | Buy |
2,284
+9
| +0.4% | +$7.9K | 0.1% | 168 |
|
|
2023
Q2 | $2.03M | Sell |
2,275
-46
| -2% | -$36.4K | 0.1% | 172 |
|
|
2023
Q1 | $1.71M | Sell |
2,321
-612
| -21% | -$437K | 0.09% | 206 |
|
|
2022
Q4 | $1.85M | Sell |
2,933
-87
| -3% | -$51.3K | 0.08% | 237 |
|
|
2022
Q3 | $1.58M | Sell |
3,020
-56
| -2% | -$33.4K | 0.08% | 259 |
|
|
2022
Q2 | $1.65M | Sell |
3,076
-127
| -4% | -$75K | 0.07% | 257 |
|
|
2022
Q1 | $2.09M | Sell |
3,203
-3,416
| -52% | -$2.19M | 0.07% | 247 |
|
|
2021
Q4 | $4.21M | Sell |
6,619
-162
| -2% | -$101K | 0.06% | 270 |
|
|
2021
Q3 | $4.24M | Sell |
6,781
-482
| -7% | -$301K | 0.06% | 249 |
|
|
2021
Q2 | $4.7M | Buy |
7,263
+9
| +0.1% | +$5.65K | 0.07% | 232 |
|
|
2021
Q1 | $4.26M | Sell |
7,254
-333
| -4% | -$196K | 0.06% | 251 |
|
|
2020
Q4 | $4.7M | Sell |
7,587
-274
| -3% | -$151K | 0.07% | 213 |
|
|
2020
Q3 | $3.73M | Buy |
7,861
+120
| +2% | +$56.4K | 0.06% | 243 |
|
|
2020
Q2 | $3.42M | Sell |
7,741
-1,604
| -17% | -$607K | 0.06% | 260 |
|
|
2020
Q1 | $2.99M | Buy |
9,345
+15
| +0.2% | +$8.17K | 0.06% | 267 |
|
|
2019
Q4 | $5.22M | Sell |
9,330
-19
| -0.2% | -$10.4K | 0.08% | 206 |
|
|
2019
Q3 | $4.87M | Sell |
9,349
-292
| -3% | -$150K | 0.08% | 214 |
|
|
2019
Q2 | $4.66M | Buy |
9,641
+522
| +6% | +$244K | 0.08% | 224 |
|
|
2019
Q1 | $4.14M | Sell |
9,119
-336
| -4% | -$136K | 0.08% | 220 |
|
|
2018
Q4 | $3.22M | Sell |
9,455
-32
| -0.3% | -$11K | 0.06% | 246 |
|
|
2018
Q3 | $3.53M | Sell |
9,487
-261
| -3% | -$94K | 0.06% | 265 |
|
|
2018
Q2 | $3.36M | Buy |
9,748
+109
| +1% | +$35.8K | 0.05% | 288 |
|
|
2018
Q1 | $2.96M | Buy |
9,639
+70
| +0.7% | +$20.6K | 0.04% | 330 |
|
|
2017
Q4 | $2.63M | Sell |
9,569
-15,407
| -62% | -$4.19M | 0.03% | 383 |
|
|
2017
Q3 | $6.38M | Sell |
24,976
-600
| -2% | -$162K | 0.04% | 437 |
|
|
2017
Q2 | $6.88M | Sell |
25,576
-909
| -3% | -$231K | 0.05% | 385 |
|
|
2017
Q1 | $5.83M | Sell |
26,485
-586
| -2% | -$140K | 0.04% | 488 |
|
|
2016
Q4 | $6.74M | Sell |
27,071
-721
| -3% | -$189K | 0.05% | 397 |
|
|
2016
Q3 | $8.04M | Sell |
27,792
-1,761
| -6% | -$494K | 0.06% | 307 |
|
|
2016
Q2 | $7.79M | Buy |
29,553
+25,559
| +640% | +$6.24M | 0.06% | 314 |
|
|
2016
Q1 | $880K | Hold |
3,994
| – | – | 0.01% | 1237 |
|
|
2015
Q4 | $912K | Buy |
3,994
+107
| +3% | +$24.1K | 0.01% | 1234 |
|
|
2015
Q3 | $826K | Hold |
3,887
| – | – | 0.01% | 1293 |
|
|
2015
Q2 | $873K | Buy |
3,887
+157
| +4% | +$35.2K | 0.01% | 1381 |
|
|
2015
Q1 | $816K | Hold |
3,730
| – | – | 0.01% | 1319 |
|
|
2014
Q4 | $732K | Buy |
3,730
+99
| +3% | +$18.7K | 0.01% | 1522 |
|
|
2014
Q3 | $669K | Sell |
3,631
-27
| -0.7% | -$4.82K | ﹤0.01% | 1526 |
|
|
2014
Q2 | $612K | Buy |
3,658
+53
| +1% | +$9.55K | ﹤0.01% | 1689 |
|
|
2014
Q1 | $668K | Hold |
3,605
| – | – | ﹤0.01% | 1607 |
|
|
2013
Q4 | $580K | Hold |
3,605
| – | – | ﹤0.01% | 1710 |
|
|
2013
Q3 | $500K | Sell |
3,605
-48
| -1% | -$6.83K | ﹤0.01% | 1747 |
|
|
2013
Q2 | $573K | Buy |
+3,653
| New | +$548K | ﹤0.01% | 1609 |
|
Other funds holding TDG
Metropolitan Life Insurance Company (MetLife)'s TDG Position: Q2 2024 in Review
Metropolitan Life Insurance Company (MetLife) sold out of TransDigm Group (TDG) in Q2 2024, closing a stake of 2,243 shares — an estimated $2.76M sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in TDG in Q2 2013 and held it in 44 quarters. The position peaked at $8.04M in Q3 2016. 1,002 funds tracked by Wall St. Rank hold TDG as of Q2 2024.
- Metropolitan Life Insurance Company (MetLife) reported no remaining TransDigm Group position as of Q2 2024 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 2,243 TransDigm Group shares in Q2 2024, an estimated $2.76M.
- Metropolitan Life Insurance Company (MetLife) first reported a position in TransDigm Group in Q2 2013 and held it in 44 quarters.
- Metropolitan Life Insurance Company (MetLife)'s TransDigm Group position peaked at $8.04M in Q3 2016.
- 1,002 funds tracked by Wall St. Rank held TransDigm Group as of Q2 2024.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.